ADGRA1-AS1
gene geneOn this page
Summary
ADGRA1-AS1 (ADGRA1 antisense RNA 1, HGNC:49543) is a long non-coding RNA gene on chromosome 10q26.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49543 |
| Approved symbol | ADGRA1-AS1 |
| Name | ADGRA1 antisense RNA 1 |
| Location | 10q26.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000256925 |
| Ensembl biotype | lncRNA |
| Entrez | 100128127 |
| RNAcentral | URS000044FA74 — lncRNA, 475 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000366099, ENST00000444433, ENST00000654383, ENST00000656946, ENST00000658362, ENST00000805858, ENST00000805859, ENST00000805860, ENST00000813526
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000366099 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001440881 | 133085256 | 133088491 |
Expression profiles
Bgee: expression breadth broad, 65 present calls, max score 74.97.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0532 / max 13.9984, expressed in 18 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 112091 | 0.0532 | 18 |
Top tissues by expression
65 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right frontal lobe | UBERON:0002810 | 74.97 | gold quality |
| primary visual cortex | UBERON:0002436 | 74.85 | gold quality |
| frontal cortex | UBERON:0001870 | 73.52 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 73.33 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.05 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 72.74 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.61 | gold quality |
| cerebral cortex | UBERON:0000956 | 72.51 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 72.42 | gold quality |
| cortex of kidney | UBERON:0001225 | 72.05 | gold quality |
| hypothalamus | UBERON:0001898 | 71.13 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 70.94 | gold quality |
| Ammon’s horn | UBERON:0001954 | 69.88 | gold quality |
| temporal lobe | UBERON:0001871 | 69.62 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 69.59 | gold quality |
| amygdala | UBERON:0001876 | 69.50 | gold quality |
| cerebellar cortex | UBERON:0002129 | 69.47 | gold quality |
| cerebellum | UBERON:0002037 | 69.36 | gold quality |
| substantia nigra | UBERON:0002038 | 66.94 | gold quality |
| brain | UBERON:0000955 | 66.75 | gold quality |
| ganglionic eminence | UBERON:0004023 | 63.49 | gold quality |
| ventricular zone | UBERON:0003053 | 63.22 | gold quality |
| multicellular organism | UBERON:0000468 | 60.77 | gold quality |
| cortical plate | UBERON:0005343 | 60.34 | gold quality |
| nucleus accumbens | UBERON:0001882 | 58.45 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 57.42 | gold quality |
| skin of leg | UBERON:0001511 | 56.21 | gold quality |
| pituitary gland | UBERON:0000007 | 56.20 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 55.55 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 55.45 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.30 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.